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Abstract
Objectives—To evaluate, in extremely low gestational age newborns (ELGANs), relationships 
between indicators of hypotension during the first 24 postnatal hours and developmental delay at 
24 months of age.
Methods—The 945 infants in this prospective study were born at < 28 weeks, were assessed for 
3 indicators of hypotension in the first 24 postnatal hours, and were evaluated with the Bayley 
Mental Development Index (MDI) and Psychomotor Development Index (PDI) at 24 months 
corrected age. Indicators of hypotension included: 1) mean arterial pressure (MAP) in the lowest 
quartile for gestational age; 2) treatment with a vasopressor; and 3) blood pressure lability, defined 
as the upper quartile for the difference between the lowest and highest MAP. Logistic regression 
was used to evaluate relationships between hypotension and developmental outcomes, adjusting 
for potential confounders.
Results—26% of the cohort had an MDI < 70 and 32% had a PDI < 70. Low MDI and PDI were 
significantly associated with low gestational age, which in turn, was associated with receipt of 
vasopressor treatment. Blood pressure in the lowest quartile for gestational age was associated 
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with vasopressor treatment and labile blood pressure. After adjusting for potential confounders, 
none of the indicators of hypotension was associated with MDI < 70 or PDI < 70.
Conclusions—In this large cohort of ELGANs, we found little evidence that early postnatal 
hypotension is associated with developmental delay at 24 months corrected gestational age.
Keywords
hypotension; blood pressure; mean arterial blood pressure; developmental delay; Bayley Scales of 
Infant Development; extremely preterm infants
Introduction
The term “cerebral blood flow autoregulation” is used to indicate that compensatory 
mechanisms can assure normal cerebral blood flow even when systemic blood pressure is 
reduced. Some preterm infants have impaired cerebral autoregulation.1, 2 However, clinical 
identification of this physiological impairment remains elusive. Nevertheless, clinicians are 
frequently advised to treat hypotension in the preterm newborn in order to avoid brain 
damage that might result from impaired cerebral blood flow autoregulation.
Conflicting results have been obtained in small observational studies of the association of 
low arterial blood pressure (variably defined) and brain damage. In some studies,3–9 but not 
in others,10–19 low blood pressure has been associated with a higher risk of intraventricular 
hemorrhage (IVH) or white matter damage identified by cranial ultrasound. The few studies 
reporting an association between hypotension and developmental delay were small and do 
not appear to have adequately controlled for potential confounders.8, 20–22
In this study, we evaluated relationships between hypotension indicators in the first 24 
postnatal hours and developmental delay at 24 months, in a large multi-center cohort of 
infants born prior to 28 weeks gestation.
Methods
The ELGAN Study was designed to identify characteristics and exposures that increase the 
risk of structural and functional neurological disorders in ELGANs (Extremely Low 
Gestational Age Newborns). During the years 2002–2004, women whose babies were 
delivered before 28 weeks gestation were asked to enroll in the study. The project was 
overseen by the National Institutes of Health, the institutional review boards of 14 
participating institutions, and an external Performance Monitoring and Safety Board 
(members appointed by the National Institutes of Neurologic Disorders and Stroke) at 
Children’s Hospital Boston. All variables and outcomes were defined a priori, and research 
personnel were trained prior to the start of the study.
Study participants
Mothers of eligible infants were approached for consent either upon antenatal admission or 
shortly after delivery, depending on clinical circumstance and institutional preference. One 
thousand two hundred forty-nine mothers consented to participate, and their 1506 infants 
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(1002 singletons, 504 twins or higher order) were enrolled. Two hundred sixty mothers were 
missed or did not consent. Infants derive from 14 institutions, 11 cities and 5 states. All 
infants were born at level III neonatal intensive care units, in either urban or suburban 
academic institutions.
Demographic, pregnancy and delivery variables
The clinical circumstances that led to each maternal admission and ultimately to each 
preterm delivery were operationally defined using data from a structured maternal interview 
and abstracted from the medical record.23 Variables evaluated as potential confounders 
included, but were not limited to, pregnancy complications and exposures (i.e. antenatal 
steroids and magnesium), placental characteristics (i.e. chorioamnionitis, funisitis, and 
thrombosis), and neonatal characteristics ascertained at birth (i.e. gestational age, race, 
gender, and anthropomorphic measurements).
Newborn variables
The gestational age estimates were based on a hierarchy of the quality of available 
information. Most desirable were estimates based on the dates of embryo retrieval, 
intrauterine insemination or fetal ultrasound before the 14th week (62%). When these were 
not available, reliance was placed sequentially on a fetal ultrasound at 14 or more weeks 
(29%), dates of the last menstrual period without fetal ultrasound (7%), and gestational age 
(1%). The birth weight Z-score and head circumference Z-score represent the number of 
standard deviations the infant’s weight or head circumference are above or below the median 
of infants at the same gestational age in a standard data set.24
Hypotension indicators
The frequency of hypotension indicators was greater in the first 24 postnatal hours than on 
subsequent days. So was the severity of hypotensive episodes. Because brain damage that 
can be attributed to severe hypotension was most likely to have occurred then, we studied 
the lowest MAP measured during the first postnatal day. Because no single definition of 
hypotension is widely accepted,19, 25 we examined three indicators of hypotension in the 
first 24 postnatal hours, including: 1) MAP in the lowest quartile for gestational age (23–24, 
25–26, and 27 weeks); 2) treatment for hypotension using a vasopressor (dopamine, 
dobutamine, epinephrine); and 3) blood pressure lability, defined as the upper quartile for the 
quantity (highest MAP – lowest MAP).
Data forms were developed prior to the start of the study, and multiple training sessions were 
held to train research personnel in standardized approaches to data collection from the 
hospital chart. The lowest, highest, and mode blood pressure measurements were abstracted 
from the medical record, for each day. We did not collect information about the method used 
for measuring blood pressure (oscillometry vs. intra-arterial catheter). MAP in the lowest 
quartile represents the lowest quartile blood pressures for a broad sample of ELGANs. 
Vasopressor use served as a “functional” definition of hypotension; regardless of how the 
clinician arrived at the decision to treat, he/she deemed the infant hypotensive enough to 
require treatment. Blood pressure lability was chosen because it has been associated with 
intraventricular hemorrhage.17
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Because 75% of the infants in this study received volume expansion in the first 24 hours, 
receipt of volume expansion was not included as a variable in analyses.
24-month developmental assessment
A developmental assessment was performed by certified examiners at 24 months corrected 
gestational age. Families were invited to bring their child for a developmental assessment, 
which included the Bayley Scales of Infant Development - Second edition (BSID-II).26 Only 
2% of examiners indicated at the time of the examination that they had more than a limited 
amount of information about the child. Before testing, examiners were told the child’s age. 
After completion of testing, examiners were told the gestational age so that the Mental 
Development Index (MDI) and Psychomotor Development Index (PDI) could be 
appropriately age-adjusted.
Developmental delay was defined as either an MDI < 70 or a PDI < 70. The child was 
classified as non-testable on a scale if her/his impairments prohibited standardized 
administration, or more than 2 items were judged to be ‘not applicable’. On the basis of their 
Vineland Adaptive Behavior Scales Composite score, 26 of 33 children considered non-
testable were assigned an MDI of < 70 (N=23) or ≥ 70 (N=3).27 On the basis of the motor 
scale (#4) of the Vineland Adaptive Behavior Scales, 32 of 38 considered non-testable were 
assigned a PDI of < 70 (N=27) or ≥ 70 (N=5).
Data analysis
We evaluated the null hypothesis that children with an indicator of hypotension during the 
first 24 postnatal hours were no more likely than their peers to have developmental delay at 
24 months.
In order to detect potential confounders, we compared the distribution of other 
characteristics and exposures among children who had each indicator of hypotension to the 
distribution among children who did not. We then compared the distribution of these 
characteristics and exposures among children who did and did not have an MDI < 70 or a 
PDI < 70.
To be identified as a potentially important confounder, characteristics and exposures of the 
pregnancy, delivery, and postnatal period had to be associated with both the exposure 
(hypotension indicator) and the outcome (low Bayley score) with a p-value ≤ 0.25. These 
were entered into time-oriented risk models that allowed antenatal and perinatal antecedents 
of hypotension indicators to be considered before variables for hypotension indicators were 
added.
Outcome measures were modeled as a dichotomy, (e.g. MDI < 70 and MDI ≥ 70), in an 
effort to minimize bias associated with detecting small, perhaps clinically unimportant 
variations in outcome appreciated with the use of continuous variables. The contribution of 
relevant characteristics and exposures to the outcome of interest are presented as odds ratios 
with 95% confidence intervals. To account for the possibility that infants born at a particular 
hospital are more like each other than infants born at other hospitals, a hospital cluster term 
was included in all models.28
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Here we present data adjusted for gestational age in groups of weeks, (i.e. 23 to 24 weeks, 
25 to 26 weeks, and 27 weeks). Early analyses included an adjustment for illness severity 
(SNAP-II).29 However, because lowest MAP in the first 12 hours is a component of SNAP-
II, it was removed from the model. Removal of the adjustment for illness severity resulted in 
no difference in adjusted risk ratios (data not shown).
Results
The three indicators of hypotension were available for 1341 (89%) of the infants in the 
ELGAN sample. At 24 months adjusted age, 1120 (84%) of these infants were alive, and 
945 (84%) were evaluated with the BSID-II (Figure 1). To evaluate the potential for bias due 
to surviving infants who were lost to follow up at 24 months of age, we compared 
characteristics of infants who returned for follow-up to those who did not (Table 1). Mothers 
who brought their child for a developmental assessment were more educated and more likely 
to be married. Their babies were born later in gestation, and were more likely to have a 
hypotension indicator.
Twenty-two percent of infants were hypotensive, defined as MAP in the lowest quartile for 
gestation, and 64% were hypotensive, defined as MAP (in mmHg) less than gestational age 
(in weeks). Due to the high proportion of infants with MAP < gestational age, any 
relationship between MAP in the lowest quartile for gestation and other characteristics, 
exposures, and abnormal development, would be statistically stronger than a relationship 
identified with MAP < than gestational age. We report only the results for hypotension 
defined as MAP in the lowest quartile for gestation.
Infant characteristics (Table 2, Figure 2)
Twenty-five percent of the entire cohort had blood pressure in the lowest quartile, whereas 
21% of survivors had a blood pressure this low, indicating an association between blood 
pressure in the lowest quartile and mortality. Twenty-six percent of infants were treated with 
vasopressors and 24% had labile blood pressure. Twenty-six percent of infants had an MDI 
< 70 and 32% had a PDI < 70.
The rate of MDI < 70 was higher in males, but males were only minimally more likely than 
females to have a hypotension indicator. Lower gestational age was associated with higher 
risk of vasopressor treatment and labile blood pressure. Lower gestational age infants were 
also at higher risk of having an MDI or PDI < 70.
Infants who had a low birth weight Z-score were at heightened risk of a blood pressure in 
the lowest quartile for gestation and labile blood pressure, but not for treatment with a 
vasopressor. Infants with a low birth weight Z-score and low head circumference Z-score, a 
correlate of low birth weight Z-score, also had a heightened risk of an MDI or PDI < 70.
Social, demographic and pregnancy characteristics (Table 3)
Indicators of social disadvantage, specifically education less than 12 years and public 
insurance, were associated with a higher rate of MDI < 70. However, because education and 
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public insurance were not associated with hypotension indicators, they are not potential 
confounders, and therefore were not included in multivariate analyses.
Univariate relationships: hypotension indicators and developmental delay (Table 4)
Vasopressors were given to less than half of infants with MAP in the lowest quartile, and one 
third of infants with a labile blood pressure. However, hypotension and vasopressor therapy 
conveyed very little information about the risk of low MDI and PDI, and labile blood 
pressure conveyed even less. Univariate analyses identified black race, public insurance, 
primigravida, male sex, gestation 23–24 weeks, and birthweight z-score < −1 as potentially 
important confounders.
Multivariate relationships: hypotension indicators and developmental delay (Figure 3)
In the unadjusted models for MDI < 70, use of vasopressors approached, but did not reach, 
statistical significance with an odds ratio of 1.4 (95% CI: 0.98–2.0). After adjusting for 
confounders, none of the indicators of hypotension studied here was significantly associated 
with an MDI < 70 or a PDI < 70.
Discussion
After controlling for potentially important confounders, we found little evidence for an 
association between early postnatal hypotension and developmental delay in a large cohort 
of extremely preterm infants.
In this study, 78% of the infants received some treatment (vasopressor or volume expansion) 
for hypotension in the first 24 postnatal hours. The proportion of infants treated for 
hypotension varied greatly among the 14 centers, even after adjustment for maternal and 
neonatal risk factors.25 Although we do not know what provoked the majority of clinicians 
to initiate treatment for hypotension, it is likely that the perception of harm to the central 
nervous system was a key motivation. To the extent that early volume expansion ameliorates 
the adverse effects of hypotension, our inferences apply only to cohorts that receive volume 
expansion liberally, as 75% of ELGANs in this study received volume expansion in the first 
24 hours. If volume expansion is not beneficial, our inferences might apply more broadly.
The correlation of blood pressure and cerebral blood flow has been studied using a number 
of techniques, including near-infrared spectroscopy,2, 30, 31 trans-cranial doppler,32, 33 
superior vena cava blood flow,33–36 and ventricular output.33, 37 While some studies have 
shown positive correlations between blood pressure and cerebral blood flow,2, 30, 32, 38, 39 
others have not.31, 33, 36, 37, 40, 41 Thus, blood pressure might not be a sensitive indicator of 
the putative effect of insufficient cerebral perfusion on the preterm brain, which might 
explain why abnormalities of cerebral blood flow have been associated with cranial 
ultrasound lesions,34, 35, 38, 42–46 but systemic hypotension has not.10–19
Our finding that early postnatal hypotension is not associated with developmental delay 
contrasts with conclusions from several prior studies of hypotension and developmental 
status assessed with the BSID-II or a similar instrument, the Griffiths Scale.8, 20–22 Studies 
reporting an association between hypotension and developmental delay were small, single-
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center studies, decreasing the likelihood that multiple potential confounders could be 
adequately controlled.8, 20–22 Hypotensive infants are frequently treated with vasopressors, 
and only two of the studies reporting an association between hypotension and developmental 
delay adequately controlled for treatment.21, 22 Further, two of the studies favoring an 
association between hypotension and developmental delay reported composite 
developmental outcomes.8, 22 Since individual outcomes do not contribute equally to 
composite measures, the overall effect estimate for a composite measure cannot be assumed 
to apply equally to each of its individual outcomes.47
Our failure to detect an association between hypotension and developmental delay has 
several possible explanations. The first and perhaps most likely is that early postnatal 
hypotension is not associated with brain damage in preterm newborns. This is what one 
would expect if the physiologic transition from intra-uterine to extra-uterine life were not 
associated with reduced cerebral blood flow.40, 48 If poor cerebral perfusion is associated 
with brain damage in preterm newborns, then our findings suggest that hypotension is not a 
reliable indicator of poor cerebral perfusion.
Because none of the potential confounders are in any way negatively associated with low 
blood pressure or low BSID, we do not consider negative confounding an explanation for 
our failure to detect an association between early postnatal hypotension and developmental 
delay.49 Our study sample was large enough to detect the confounding influence of treatment 
(with vasopressors) on outcome, and our results suggest a near-significant association 
between vasopressor use and developmental delay. A possible explanation for this finding is 
that use of vasopressors could have adverse effects. An alternative explanation is that the 
severe physiologic abnormalities that prompted therapy provide information about the risk 
of brain damage. This would occur if clinicians provided therapy to those infants at highest 
risk of morbidities, e.g. infants born at lower gestational age,50 a bias referred to as 
confounding by indication.51–53
The strengths of our study include the use of prospectively collected data from a large 
multicenter cohort, defined by gestational age (rather than birth weight),54 and the use of 
follow up data collected by examiners who were trained in the standardized administration 
of the BSID-II. Examiners were masked to infants’ medical histories, including the infant’s 
corrected gestational age at the follow-up visit.
A potential limitation of our study is the lack of a consistent method for obtaining MAP. 
Some MAP measurements were obtained by intra-arterial catheters, others by oscillometry. 
The latter method overestimates blood pressure.55, 56 The direction of the resulting bias 
would depend on whether an association exists between the method by which infants’ blood 
pressures were measured and their risks of developmental delay. Other limitations include 
the intermittent collection of MAP data, and the possibility that we missed the lowest MAP 
during the first 24 hours. Since a large proportion of ELGANs in this study received volume 
expansion, we are unable to speculate regarding the effects of hypotension on developmental 
status for cohorts in which volume expansion is used sparingly. We also acknowledge that 
the agreement between early developmental assessments (20 to 24 months) and school-age 
outcomes (5 to 8 years) is not strong.57
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We did not report on the presence or absence of acidosis for two reasons. First, the available 
data did not permit a temporal correlation between recorded blood pressure and blood gas 
measurements. Second, hypotension is only one of a number of events that contribute to 
acidosis in the early postnatal period. These factors include, but are not limited to, utero-
placental insufficiency, abruptio-placenta, maternal medications, and chorioamnionitis. 
Consequently, acidosis reflects much more than poor systemic perfusion in the early 
postnatal period, and cannot be viewed as a surrogate for poor perfusion. Therefore, we 
chose to address only the contribution of early postnatal hypotension to developmental 
outcomes.
Despite these limitations, our study has implications for researchers interested in preventing 
developmental delay in extremely preterm infants. Specifically, our study casts doubt on the 
concept that early postnatal hypotension is an important risk factor for such delays, and the 
corollary that interventions to increase blood pressure can prevent such delays.
The implications for clinicians are important as well, as ELGANs are frequently given 
treatments to increase blood pressure under the assumption that these treatments decrease 
the risk of brain injury. This assumption is not supported by observational studies,{Kuint, 
2008 #101;Dempsey, 2009 #125} and there is a paucity of support for therapies widely used 
to treat hypotension.{Pellicer, 2009 #127;Dempsey, 2007 #41} Treatment for hypotension 
has been associated with abnormal development,{Kuint, 2008 #101;Greenough, 2002 
#50;Fanaroff, 2006 #42} hearing loss,{Kuint, 2008 #101;Fanaroff, 2006 #42} and severe 
brain ultrasound abnormalities in low birth weight infants.{Kuint, 2008 #101;Goldberg, 
1980 #51;Salafia, 1995 #43;O’Shea, 1998 #90;Synnes, 2001 #94;Greenough, 2002 
#50;Batton, 2007 #44} Thus, while it is possible that the decision to treat reflects the 
physician’s perception that the infant is vulnerable, it is also suggests the possibility that 
these therapies are harmful.
In conclusion, we found that hypotension and therapy for hypotension during the first 24 
postnatal hours is associated with a small increased risk for a low MDI, which despite our 
large sample of 945 infants did not achieve statistical significance.
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What is already known on this topic
The available literature contains conflicting results regarding the association of low 
arterial blood pressure and brain damage in ELGANs. In some studies, low blood 
pressure has been associated with an increased risk of brain damage identified by cranial 
ultrasound, while in other studies these associations were not found. The few studies 
reporting an association between hypotension and developmental delay were small, and 
do not appear to have adequately controlled for potential confounders.
What this study adds
This study casts some doubt on the concept that early postnatal hypotension is associated 
with developmental delay, and the corollary that treatment for hypotension improves 
developmental outcomes. Contrary to the findings of others, we found little evidence for 
an association between early postnatal hypotension and developmental delay in a large 
cohort of extremely preterm infants. Our findings should provide some motivation for the 
development of clinical trials that address questions regarding hypotension and 
developmental outcomes.
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Sample for analyses of hypotension and developmental delay
Logan et al. Page 15














Lowest MAP (mmHg) in the first 24 hours and Gestational Age (weeks). The bottom of 
each dark box marks the upper boundary of the lowest quartile, and measures below this 
boundary are those that were included in our analysis as a hypotension indicator. Asterisks 
represent outliers.
Logan et al. Page 16














Odds ratios (and 95% confidence intervals) of the risk of MDI <70 and PDI <70 obtained 
with logistic regression models that incorporate indicators of hypotension during the first 24 
postnatal hours and potential confounders.
* Adjustedfor black race, public insurance, primagravida, male sex, gestational age 23–24 
weeks, birth weight Z-score < −1, and center
** Adjusted for public insurance, male sex, multiple birth, gestational age 23–24 weeks, 
birth weight Z-score < −1, and center
§Lowest ¼ile MAP: lowest MAP recorded in the first 24 hours, in the lowest quartile for 
gestational age
¶Vasopressor: treatment for hypotension in the first 24 hours, using any vasopressor 
(dopamine, dobutamine, epinephrine)
†Labile MAP: labile blood pressure, defined as the upper quartile of the difference in the 
lowest and highest MAP
MDI Mental Developmental Index
PDI Psychomotor Developmental Index
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Table 1
Comparison of characteristics of mothers and children who were followed to those of mothers and children 
who were not. Presented as column percents.
Maternal or infant characteristic Followed Not followed
Maternal education < 12 18 24
12 (High school) 26 28
>12 to <16 23 28
College grad 18 14
> 16 14 6
Married Yes 56 44
Public insurance Yes 41 50




Cerv insufficiency 5 7
Fetal Indication 3 6
Sex Male 53 55
Black race Yes 27 27
Gestational age (wks) 23–24 20 26
25–26 47 46
27 33 29
Birth weight Z-score < −2 6 3
≥ −2, < −1 12 11
> −1 82 86
Head circumference Z-score < −2 8 5
≥ −2, < −1 23 20
> −1 69 75
Lowest ¼ile MAP§ Yes 22 15
Vasopressor ¶ Yes 26 19
Labile MAP† Yes 24 17




Lowest ¼ile MAP: lowest MAP recorded in the first 24 hours, in the lowest quartile for gestational age
¶
Vasopressor: treatment for hypotension in the first 24 hours, using any vasopressor (dopamine, dobutamine, epinephrine)
†
Labile MAP: labile blood pressure, defined as the upper quartile of the difference in the lowest and highest MAP
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